Home | Site Map
 
 
[.:Menù:.]
[.:Contenuti:.]
ENDOCRINE SYSTEM

New Data Shows Rimonabant Benefited Patients With Type 2 Diabetes By Improving Blood Sugar Control And Reducing Weight Medical News Today
Sanofi-aventis announced today that new data on rimonabant, its first-in-class cannabinoid type 1 (CB1) receptor blocker, showed that patients with type 2 diabetes not currently treated with anti-diabetic medications experienced significant improvements in blood sugar control and weight as we [click link for full article]
sanofi-aventis announces data on rimonabant PharmaBiz
sanofi-aventis announced that new data on rimonabant, its first-in-class cannabinoid type 1 (CB1) receptor blocker, showed that patients with type 2 diabetes not currently treated with anti-diabetic medications experienced significant improvements in blood sugar control and weight as well as other risk factors such as HDL-cholesterol (good cholesterol) and triglycerides when compared to placebo.
How Mammals Fuel Milk Production May Have Implications For Cancer Science Daily
In a new study in the December issue of the journal Cell Metabolism, published by Cell Press, the researchers found that one of three "isoforms" of the gene known as Akt is specifically required for lactating mice to synthesize sufficient quantities of milk to support their offspring. While the loss of so-called Akt1 does not lead to structural abnormalities, they found, mothers deficient for the
Confessions of a Serial Whistleblower Pharmaceutical Executive
Before the conversation could get underway, Peter Rost plants a stake in the ground. "I'm not a crazy man," says Rost. "I just wanted to do my job well enough to one day run my own drug company."
PRW.com - Plastics Industry News Plastics and Rubber Weekly
Substitution aspect under BPF scrutiny. 4 December 2006 – The British Plastics Federation (BPF) and its sister federations across Europe are studying an agreement struck on Friday (December 1) on the final shape of the European Union’s (EU) REACH chemical control system.
Acomplia Rimonabant Helps Type 2 Diabetes Patients Improve Blood Sugar, Lose Weight, Lower Heart Risks Senior Journal
December 5, 2006 – In the latest testing of Acomplia (rimonabant) for treating diabetes over 50% of previously untreated patients achieved HbA1c levels below 7%, the target for good glucose control as recommended by the American Diabetes Association, plus reductions in body weight of 14.8 lbs.
New Data Shows AcompliaR Rimonabant Benefited Patients With Type 2 Diabetes by Improving Blood Sugar Control, FinanzNachrichten
Sanofi-aventis announced today that new data on rimonabant, its first-in-class cannabinoid type 1 (CB1) receptor blocker, showed that patients with type 2 diabetes not currently treated with anti-diabetic medications experienced significant improvements in blood sugar control and weight as well as other risk factors such as HDL-cholesterol (good cholesterol) and triglycerides when compared to
Kundalini Yoga instructor: Mind , body come together to improve life Wisconsin State Journal
I guess I'd have to say that my mother was really the first to introduce me to yoga. I wasn't super athletic, but I did like low-impact sports.
Running the Bases AME Info
Running is a popular pastime many people follow in their pursuit of fitness. You don't have to be an elite or competitive runner to take advantage of a very simple, yet highly productive, technique for improving your running skills.
New Data Shows Acompliar Rimonabant Benefited Patients With Type 2 Diabetes by Improving Blood Sugar Control, CNW Group via Yahoo! Finance
Sanofi-aventis announced today that new data on rimonabant, its first-in-class cannabinoid type 1 receptor blocker, showed that patients with type 2 diabetes not currently treated with anti-diabetic medications experienced significant improvements in blood sugar control and weight as well as other risk factors such as HDL-cholesterol and triglycerides when compared to placebo.
endocrine+system: endocrine system disorder | picture of the endocrine system | endocrine system disorder | picture of the endocrine system | endocrine+system
Cerca con Google


 
 
©2006 home |azienda | flotta | privacy | Contatti | endocrine+system Tutti i diritti sono riservati.